Latest Conference Articles

Using A Streamlined Workflow to Identify Particulates in Biologic Drugs

November 11th 2025

In a poster presentation at AAPS PharmSci 360, Eda Fenercioglu, a scientist at Pfizer, outlines a streamline workflow for identifying and mitigating visible particles in biologic drugs.

AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis

November 11th 2025

Pharmaceutical Technology® spoke with Steve Lowes, senior director of Scientific Affairs at IQVIA Laboratories, ahead of AAPS PharmSci 360 to discuss some of the unique instruments used to conduct bioanalysis.

Why Context Matters in Validating Biomarker Assays for Bioanalysis

November 10th 2025

Pharmaceutical Technology® spoke with Steve Lowes, senior director of Scientific Affairs at IQVIA Laboratories, ahead of AAPS PharmSci 360 to discuss method validation of biomarker bioanalysis.

Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge

November 10th 2025

In a poster presentation at AAPS PharmSci 360, by Dineli Ranathunga, PhD, indicates that AI/ML in-silico modeling can accelerate poorly soluble drug development.

Why Investment Strategies Matter for Advancing Pharmaceutical Technologies

November 7th 2025

PharmSci 360 will spotlight the economics behind AI, scale-up, and advanced modalities, addressing cost barriers that influence future drug manufacturing.

AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies

November 7th 2025

Pharmaceutical Technology® spoke with Dr. Mark Arnold, owner and principal, Bioanalytical Solution Integration, ahead of AAPS PharmSci 360 to find out how bioanalysis enhances bio/pharmaceutical drug development.

AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis

November 7th 2025

Pharmaceutical Technology® spoke with Steve Lowes, senior director of Scientific Affairs at IQVIA Laboratories, ahead of AAPS PharmSci 360 to discuss how LC–MS is used in bioanalysis.

How AI, Machine Learning, and Large Language Models Enhance Bioanalysis

November 7th 2025

Long Yuan, PhD, director of the Department of Drug Metabolism and Pharmacokinetics at Biogen, explains how artificial intelligence, machine learning, and large language models are used in performing bioanalysis.

2025 AAPS PharmSci 360 to Highlight Next-Gen AI for Drug Development

November 7th 2025

AAPS PharmSci 360 will spotlight AI advances, gene therapy progress, and leading pharma research insights this year, says programming chair Mei He.

Building Trusted CDMO Relationships: A CPHI Conversation with Thermo Fisher Scientific, Part Two

November 7th 2025

CPHI Europe

Thermo Fisher’s Jennifer Cannon reviews the first year of the company’s Accelerator Drug Development suite of services and the overall experience of attending the CPHI conference.